🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementNausea incidence by dose tier — 6 month update Page 3

Nausea incidence by dose tier — 6 month update

Dr.LeslieOBGYN Thu, Aug 7, 2025 at 3:48 PM 12 replies 1,370 viewsPage 3 of 3
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Aug 11, 2025 at 8:29 AM#11
pat_auckland said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

Last edited: Aug 11, 2025 at 11:29 AM
5 3Dr.LeslieOBGYN, MikeNYC_runner and 2 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Aug 12, 2025 at 9:17 AM#12
Dr.AddMedPHL said:
Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything.

This is exactly what I could not find anywhere else. I will report back once I have actually tried it.

6 4LeilaHI, marcus_mpls, DeniseRN_TPA and 3 others
Reply Quote Save Share Report
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Aug 13, 2025 at 10:04 AM#13
pat_auckland said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Pushing back on pat_auckland here. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

Last edited: Aug 13, 2025 at 11:04 AM
7 5hyun_seoul, jim_asheville, matt_MKE and 4 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Aug 14, 2025 at 10:51 AM#14

The figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Last edited: Aug 14, 2025 at 2:51 PM
8 6FranDenver, Dr.BariatricHTX, LindaRN_retired and 5 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Aug 15, 2025 at 11:37 AM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out. Report rather than reply if it drifts again.

9 7PurityPaulOR, MaxMetOK, MounjBrad and 6 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register